Sign in
4

Changes in Ownership

Anixa Biosciences Inc Filed Acc 0001493152-22-017926

Director acquired 46,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Titterton Lewis H jr · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-06-24 Exercise or conversion : show line 1 in the form +30,000 $2.58 $77,250 1,018,070 D
2022-06-24 Exercise or conversion : show line 2 in the form +16,000 $2.58 $41,200 1,034,070 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-06-24 Exercise or conversion : show line 3 in the form Employee Stock Option −30,000 0 D
2022-06-24 Exercise or conversion : show line 4 in the form Employee Stock Option −16,000 0 D
Loading xslF345X03/ownership.xml…